ArticleCureus2025
Analysis of Overactive Bladder Symptom Score Improvement in Lower Urinary Tract Symptom Patients During Behavioral Therapy While Using the Smartphone Application "USAPO".
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAccording to Japanese lower urinary tract symptom (LUTS) guidelines, behavioral therapy is recommended as a first-line treatment for LUTS. However, the guidance provided during outpatient visits alone may not be sufficiently effective, as patients are unlikely to change their behavior. This study aimed to evaluate the changes in urinary storage symptoms after sustained intervention using a mobile application.
methodsChanges in Overactive Bladder Symptom Score (OABSS) resulting from the sustained intervention were assessed among users of the mobile application "USAPO."
resultsA total of 139 patients were included in this study. The OABSS before and after using USAPO was 2.03±2.42 and 2.25±2.826 points, respectively, with no significant difference (p=0.2194). The group with at least a one-point improvement in OABSS showed a statistically significant trend in age (p=0.055) and a statistically significant difference in the severity of urinary storage symptoms compared to the non-responding group (p<0.0001).
conclusionsAlthough no overall change in OABSS was observed with the introduction of USAPO, a subset of patients may benefit from its use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.